# TCM as an Adjuvant Treatment in Mycobacterium Abscessus Pulmonary Disease

> **NCT07295938** · PHASE2 · RECRUITING · sponsor: **Shanghai University of Traditional Chinese Medicine** · enrollment: 352 (estimated)

## Conditions studied

- Mycobacterium Abscessus Pulmonary Disease

## Interventions

- **DRUG:** Chinese herbs-I
- **DRUG:** Chinese herbs-I placebo
- **DRUG:** Chinese herbs-II
- **DRUG:** Chinese herbs-II placebo

## Key facts

- **NCT ID:** NCT07295938
- **Lead sponsor:** Shanghai University of Traditional Chinese Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-08
- **Primary completion:** 2028-11
- **Final completion:** 2028-11
- **Target enrollment:** 352 (ESTIMATED)
- **Last updated:** 2025-12-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07295938

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07295938, "TCM as an Adjuvant Treatment in Mycobacterium Abscessus Pulmonary Disease". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT07295938. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*